Last week, federal health officials called for a pause in the use of the Johnson & Johnson coronavirus vaccine after there were six reports of blood clots in women who had received the shot. About 7 million doses of the single-shot vaccine have been administered in the United States, accounting for less than 5 percent of all vaccinations so far.

A federal vaccine advisory committee said Wednesday that it will reconvene within 10 days, after collecting more information regarding the six cases. The problems are so far rare, but there are symptoms to watch for if you’ve already received the vaccine.

The White House has said there is more than enough of the Pfizer and Moderna vaccine to go around while officials review the Johnson & Johnson vaccine.

The Washington Post’s Angela Fritz, Ben Guarino and Joel Achenbach answered questions about the pandemic and the vaccines on Monday. Here are some of the questions they tackled:

Read the full transcript below.

Looking for more? Check out some of our previous coverage:

Sign up to get the most important developments about the coronavirus pandemic straight to your inbox every weekday. All stories in the newsletter are free to access.

Teddy Amenabar, an editor on The Post’s audience team, produced this Q&A.